JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nye, J. A.
Right arrow Articles by Goodman, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nye, J. A.
Right arrow Articles by Goodman, M. M.
Journal of Nuclear Medicine Vol. 49 No. 12 2018-2025
© 2008 by Society of Nuclear Medicine

doi: 10.2967/jnumed.108.054262

Clinical Investigation

Compartmental Modeling of 11C-HOMADAM Binding to the Serotonin Transporter in the Healthy Human Brain

Jonathon A. Nye1,2, John R. Votaw1,2, Nachwa Jarkas1,2, David Purselle3, Vernon Camp2, James D. Bremner1–3, Clinton D. Kilts3, Charles B. Nemeroff3 and Mark M. Goodman1–3

1 Department of Radiology, Emory University, Atlanta, Georgia; 2 Emory University Center for Positron Emission Tomography, Emory University, Atlanta, Georgia; and 3 Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, Georgia

Correspondence: For correspondence or reprints contact: Jonathon A. Nye, Department of Radiology, 1365 Clifton Rd. NE, Atlanta, GA 30322. E-mail: jnye{at}emory.edu

The novel PET radioligand 11C-N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine (11C-HOMADAM) binds with high affinity and selectively to the serotonin transporter (SERT). The purpose of this study was to develop a reliable kinetic model to describe the uptake of 11C-HOMADAM in the healthy human brain. Methods: Eight volunteers participated in the study; 5 of them were fitted with arterial catheters for blood sampling and all were scanned on a high-resolution research tomograph after the injection of 11C-HOMADAM. Regional distribution volumes and binding potentials were calculated with 2- and 4-parameter arterial-input compartment models, a 3-parameter reference tissue compartment model, and the Logan graphic approach. Results: The 2-parameter arterial-input compartment model was statistically superior to the 4-parameter model and described all brain regions. Calculated binding potentials agreed well between the arterial-input model and the reference tissue model when the cerebellum was used as the reference tissue. The Logan graphic approach was not able to estimate the higher concentration of SERT in the dorsal raphe than in the midbrain. Conclusion: 11C-HOMADAM is a highly promising radioligand with high ratios of specific binding to nonspecific binding in known SERT-rich structures, such as the raphe nuclei. The 3-parameter reference tissue model approach permits a simplified quantitatively accurate method for estimating SERT binding potentials.

Key Words: PET • serotonin transporter • kinetic modeling

COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2008 49: 11A-12A. [Full Text]  



This article has been cited by other articles:


Home page
Clin. Chem.Home page
C. B. Nemeroff and M. J. Owens
The Role of Serotonin in the Pathophysiology of Depression: As Important As Ever
Clin. Chem., August 1, 2009; 55(8): 1578 - 1579.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2008 by the Society of Nuclear Medicine.